Breakthrough Cancer Research Education and Travel Award 2025
The Breakthrough Cancer Research Education & Travel Award 2025 supports doctoral researchers in furthering their cancer research through travel opportunities. This award is intended for PhD students who:
-
Wish to present their research findings via a poster or oral presentation at national or international conferences, symposia, or workshops.
-
Need to visit another laboratory to acquire a specialized technique not available at their current institution.
In 2025, a number of bursaries were awarded, each providing up to €500 in reimbursed expenses for research-related travel. The eligible travel period was from the 20th of January to the 31st October 2025.
Purpose of the Award
The Breakthrough Cancer Research Education & Travel Award 2025 aimed to:
-
Facilitate networking and professional development through active participation in academic conferences.
-
Support hands-on training in advanced research techniques by funding visits to external laboratories.
2025 AWARDEES
- Aidan O’Dowling from University College Dublin (supervisor: Dr. Stephen Thorpe) attended the American Society of Clinical Oncology, Gastrointestinal Cancers Symposium 2025 on the 22nd – 26th of January 2025 at Moscone Center, in San Francisco (USA). He presented a poster titled “Impact of Pancreatic Tumor Biomechanics on Diagnosis and Post-Operative Complications”.
- Aislinn Duggan from University College Dublin (supervisor: Dr. Claire Robinson) attended the Irish Association for Cancer Research (IACR) Annual Conference 2025 on the 5th – 7th of March 2025 at Europa Hotel, in Belfast (Northen Ireland). She presented a poster titled “The IRE1-XBP1s pathway is active in pancreatic ductal adenocarcinoma (PDAC) associated stellate cell”.
- David Hackett from Trinity College Dublin (supervisor: Prof. Stephen Maher) attended the European Society for Medical Oncology (ESMO) Targeted Anticancer Therapies (TAT) Congress 2025 on the 2nd – 5th of March 2025 at Marriott Rive Gauche Hotel, in Paris (France). He presented a poster titled “Identification of the molecular mechanism underpinning miR-31-mediated alterations in platinum agent chemosensitivity in pancreatic ductal adenocarcinoma”. His poster received the “Best Poster Prize” in the Cellular and Gene Therapies category.
- Rabia Saleem from Royal College of Surgeons in Ireland (supervisor: Dr. Olga Piskareva) attended the Irish Association for Cancer Research (IACR) Annual Conference 2025 on the 5th – 7th of March 2025 at Europa Hotel, in Belfast (Northen Ireland). She presented a poster titled “HDAC inhibitor Vorinostat alters Glypican-2 expression in Cisplatin resistant neuroblastoma cell model”
- Eve O’Donoghue from Royal College of Surgeons in Ireland (supervisor: Dr. Olga Piskareva) attended the Irish Association for Cancer Research (IACR) Annual Conference 2025 on the 5th – 7th of March 2025 at Europa Hotel, in Belfast (Northen Ireland). She presented a poster titled “Characterising GPC2 In Lung Cancer: From Differential Expression to Therapeutic Potential”.
- Jamie Casey from Maynooth University (supervisor: Dr. Marion Butler) attended the Irish Association for Cancer Research (IACR) Annual Conference 2025 on the 5th – 7th of March 2025 at Europa Hotel, in Belfast (Northen Ireland). He presented a poster titled “Investigation on how SHP2 tyrosine phosphatase inhibition slows the growth of high-grade carcinoma cells with the aim to develop new treatment for ovarian cancer”.
- Joyce Barry from Trinity College Dublin (supervisor: Dr. Melissa Conroy) attended the Irish Association for Cancer Research (IACR) Annual Conference 2025 on the 5th – 7th of March 2025 at Europa Hotel, in Belfast (Northen Ireland). She presented two posters titled “Investigating the applicability of cytokine-induced memory-like NK cell therapy for oesophageal adenocarcinoma” (for the Biomedical Session) and “Improving the cancer-fighting ability of our immune system” (for the Paddy Johnston’s Session).
Back
Start year
2025
End year
2025
Grant Type
Breakthrough Cancer Research Education & Travel Award 2025
Awardees
Aidan O'Dowling, Aislinn Duggan, David Hackett, Rabia Saleem, Eve O’Donoghue, Jamie Casey
Linked Breakthrough Research Priorities
Increase research investment into poor prognosis cancers and currently incurable cancers prioritising lung, oesophageal, ovarian, pancreatic, brain, liver and stomach cancers.
Improve integration of cancer research into cancer care in Ireland and increase clinical capacity by prioritising funding for projects and programmes with significant clinical engagement.
Fund the discovery and development of new therapeutics, surgical approaches and technologies, including biological and immune approaches, to improve cancer treatment.
Fund research which aims to improve the effectiveness or specificity of current cancer therapies including investing in biomarkers discovery, nutrition and therapeutic delivery.
Invest in research harnessing the potential of big data to improve cancer detection, personalised treatment and patient outcomes.
Invest in research-led innovation at every stage of the cancer patient journey from first diagnosis through to treatment, clinical trials and palliative care to improve survival and quality of life.